6 Vaccines Approved for Use in South Africa
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
7 trials in 3 countries
Approval Source: seekingalpha.com
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: sahpra.org.za
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: forbes.com
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
6 trials in 1 country
Approval Source: indiatoday.in
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
Approval Source: bloomberg.com
21 Vaccines in Clinical Trials in South Africa
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
15 trials in 13 countries
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
7 trials in 3 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 35 countries
3 trials in 5 countries
-
Providence Therapeutics Holdings Inc.
PTX-COVID19-B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Clover
SCB-2020S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
AAHI-SC2 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
AAHI-SC3 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162b2 (B.1.1.7 + B.1.617.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Pfizer/BioNTech
BNT162b2 (B.1.1.7)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Pfizer/BioNTech
BNT162b2 (B.1.617.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
ImmunityBio Inc
hAd5-Covid-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
7 trials in 2 countries
-
Scancell
COVIDITY- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Gritstone bio, Inc.
GRT-R912- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Gritstone bio, Inc.
GRT-R914- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Gritstone bio, Inc.
GRT-R918- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country